Deutsche Bank reiterates Buy on Jazz Pharmaceuticals
Deutsche Bank maintained its Buy rating on Jazz Pharmaceuticals, according to TradingView News.
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.